John P. Sheehan

Array ( [id] => 8708536 [patent_doc_number] => 20130065825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'Compositions and Methods for Delaying Senescence or Cell Death in Neurons' [patent_app_type] => utility [patent_app_number] => 13/613030 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13924 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338828 [patent_doc_number] => 20140065610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'METHOD FOR PREDICTING CLINICAL BENEFIT IN THE TREATMENT OF NEURODEVELOPMENTAL, NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/590211 [patent_app_country] => US [patent_app_date] => 2012-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13084 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11874715 [patent_doc_number] => 09746482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease' [patent_app_type] => utility [patent_app_number] => 14/237966 [patent_app_country] => US [patent_app_date] => 2012-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16393 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495442 [patent_doc_number] => 20120294850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Ganglioside Epitopes For Treating Guillain-Barre Syndrome' [patent_app_type] => utility [patent_app_number] => 13/563084 [patent_app_country] => US [patent_app_date] => 2012-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25041 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13563084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940433 [patent_doc_number] => 20130190230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING COGNITIVE DEFICITS' [patent_app_type] => utility [patent_app_number] => 13/561325 [patent_app_country] => US [patent_app_date] => 2012-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16287 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9698549 [patent_doc_number] => 20140248234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'USE OF G-CSF DIMER IN PREPARATION OF MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/233739 [patent_app_country] => US [patent_app_date] => 2012-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11823 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12948559 [patent_doc_number] => 09835621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-05 [patent_title] => Process for detection of alzheimer's disease from a serum sample [patent_app_type] => utility [patent_app_number] => 14/232863 [patent_app_country] => US [patent_app_date] => 2012-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 10974 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9223475 [patent_doc_number] => 20140018250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/549307 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38478 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10912974 [patent_doc_number] => 20140315992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism' [patent_app_type] => utility [patent_app_number] => 14/131359 [patent_app_country] => US [patent_app_date] => 2012-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14105 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892201 [patent_doc_number] => 20130165385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'NEUROGENIN' [patent_app_type] => utility [patent_app_number] => 13/533279 [patent_app_country] => US [patent_app_date] => 2012-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19803 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113072 [patent_doc_number] => 08569241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Composition for improving brain function and method for improving brain function' [patent_app_type] => utility [patent_app_number] => 13/532394 [patent_app_country] => US [patent_app_date] => 2012-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13074 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9435034 [patent_doc_number] => 20140112940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'MYCOTOXIN DIAGNOSTICS AND METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/127493 [patent_app_country] => US [patent_app_date] => 2012-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19838 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8522236 [patent_doc_number] => 20120321644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'METHODS FOR DIAGNOSING MOOD DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/523063 [patent_app_country] => US [patent_app_date] => 2012-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24423 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9384535 [patent_doc_number] => 20140088017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME' [patent_app_type] => utility [patent_app_number] => 14/119891 [patent_app_country] => US [patent_app_date] => 2012-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14663 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393142 [patent_doc_number] => 20120230986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'Agent and Methods for Reducing Inflammatory Markers' [patent_app_type] => utility [patent_app_number] => 13/463851 [patent_app_country] => US [patent_app_date] => 2012-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2903 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9838528 [patent_doc_number] => 20150030609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'DIAGNOSIS AND TREATMENT OF TRAUMATIC BRAIN INJURY' [patent_app_type] => utility [patent_app_number] => 14/006557 [patent_app_country] => US [patent_app_date] => 2012-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18061 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11536895 [patent_doc_number] => 09611292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-04 [patent_title] => 'Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction' [patent_app_type] => utility [patent_app_number] => 14/113763 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 6856 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977489 [patent_doc_number] => 09023800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Peptides for the treatment of oxidative stress related disorders' [patent_app_type] => utility [patent_app_number] => 13/452986 [patent_app_country] => US [patent_app_date] => 2012-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 14200 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10517038 [patent_doc_number] => 09244082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-26 [patent_title] => 'Detection and treatment of LRP4-associated neurotransmission disorders' [patent_app_type] => utility [patent_app_number] => 13/452018 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 21576 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834322 [patent_doc_number] => 08450077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Quantitative diagnostic methods using multiple parameters' [patent_app_type] => utility [patent_app_number] => 13/446382 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 28 [patent_no_of_words] => 14320 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446382 [rel_patent_id] =>[rel_patent_doc_number] =>)